Craig Sponseller, MD

Chief Medical Officer
Kowa Pharmaceuticals America, Inc.
Montgomery, Alabama

Presentation(s):

• Poster Number-74 - CELECOXIB-TRAMADOL HYDROCHLORIDE CO-CRYSTAL IN PATIENTS WITH MODERATE-TO-SEVERE PAIN FOLLOWING BUNIONECTOMY WITH OSTEOTOMY: SECONDARY ANALYSES OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, FACTORIAL, ACTIVE- AND PLACEBO-CONTROLLED TRIAL

  Poster Abstracts

• Poster Number-69 - CELECOXIB-TRAMADOL HYDROCHLORIDE CO-CRYSTAL SAFETY, TOLERABILITY, AND DIFFERENTIAL PHARMACOKINETICS: A SUMMARY OF FIVE PHASE 1 RANDOMIZED CLINICAL TRIALS

  Poster Abstracts